BNP Paribas Financial Markets’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $274M | Sell |
1,966,938
-965,546
| -33% | -$135M | 0.13% | 144 |
|
|
2025
Q4 | $360M | Buy |
2,932,484
+1,122,901
| +62% | +$136M | 0.16% | 110 |
|
|
2025
Q3 | $201M | Sell |
1,809,583
-205,498
| -10% | -$23.4M | 0.11% | 175 |
|
|
2025
Q2 | $223M | Sell |
2,015,081
-1,212,069
| -38% | -$129M | 0.13% | 141 |
|
|
2025
Q1 | $362M | Sell |
3,227,150
-319,642
| -9% | -$33M | 0.21% | 97 |
|
|
2024
Q4 | $328M | Buy |
3,546,792
+709,367
| +25% | +$63.9M | 0.18% | 100 |
|
|
2024
Q3 | $238M | Sell |
2,837,425
-85,510
| -3% | -$6.52M | 0.16% | 131 |
|
|
2024
Q2 | $201M | Buy |
2,922,935
+848,004
| +41% | +$56.6M | 0.16% | 130 |
|
|
2024
Q1 | $152M | Buy |
2,074,931
+283,396
| +16% | +$21.8M | 0.13% | 156 |
|
|
2023
Q4 | $145M | Buy |
1,791,535
+790,088
| +79% | +$61.5M | 0.16% | 140 |
|
|
2023
Q3 | $75M | Sell |
1,001,447
-389,357
| -28% | -$29.9M | 0.1% | 212 |
|
|
2023
Q2 | $107M | Buy |
1,390,804
+280,478
| +25% | +$22.4M | 0.13% | 148 |
|
|
2023
Q1 | $92.1M | Sell |
1,110,326
-182,332
| -14% | -$15.1M | 0.13% | 155 |
|
|
2022
Q4 | $111M | Buy |
1,292,658
+628,511
| +95% | +$49.8M | 0.17% | 127 |
|
|
2022
Q3 | $41M | Sell |
664,147
-254,836
| -28% | -$16.1M | 0.07% | 351 |
|
|
2022
Q2 | $56.8M | Sell |
918,983
-196,182
| -18% | -$12.1M | 0.09% | 253 |
|
|
2022
Q1 | $66.3M | Sell |
1,115,165
-392,925
| -26% | -$25.1M | 0.09% | 229 |
|
|
2021
Q4 | $110M | Sell |
1,508,090
-255,860
| -15% | -$17.6M | 0.16% | 136 |
|
|
2021
Q3 | $123M | Sell |
1,763,950
-707,909
| -29% | -$49.7M | 0.17% | 124 |
|
|
2021
Q2 | $170M | Buy |
2,471,859
+1,203,966
| +95% | +$80.4M | 0.23% | 98 |
|
|
2021
Q1 | $81.9M | Buy |
1,267,893
+469,553
| +59% | +$30.3M | 0.12% | 188 |
|
|
2020
Q4 | $46.5M | Sell |
798,340
-1,785,311
| -69% | -$108M | 0.09% | 226 |
|
|
2020
Q3 | $163M | Buy |
2,583,651
+1,214,993
| +89% | +$84.3M | 0.23% | 78 |
|
|
2020
Q2 | $105M | Sell |
1,368,658
-1,273,611
| -48% | -$97.6M | 0.19% | 110 |
|
|
2020
Q1 | $198M | Buy |
2,642,269
+1,445,483
| +121% | +$99.9M | 0.41% | 42 |
|
|
2019
Q4 | $77.8M | Sell |
1,196,786
-604,177
| -34% | -$39.3M | 0.14% | 146 |
|
|
2019
Q3 | $114M | Sell |
1,800,963
-206,244
| -10% | -$13.5M | 0.2% | 102 |
|
|
2019
Q2 | $136M | Buy |
2,007,207
+30,673
| +2% | +$2.02M | 0.27% | 79 |
|
|
2019
Q1 | $128M | Buy |
1,976,534
+62,858
| +3% | +$4.18M | 0.28% | 70 |
|
|
2018
Q4 | $120M | Sell |
1,913,676
-1,360,163
| -42% | -$95.1M | 0.28% | 65 |
|
|
2018
Q3 | $253M | Buy |
3,273,839
+1,454,113
| +80% | +$110M | 0.37% | 40 |
|
|
2018
Q2 | $129M | Sell |
1,819,726
-137,422
| -7% | -$9.7M | 0.21% | 90 |
|
|
2018
Q1 | $148M | Buy |
1,957,148
+345,058
| +21% | +$27.4M | 0.28% | 65 |
|
|
2017
Q4 | $115M | Sell |
1,612,090
-558,334
| -26% | -$42.4M | 0.2% | 97 |
|
|
2017
Q3 | $176M | Buy |
2,170,424
+356,044
| +20% | +$27.2M | 0.43% | 46 |
|
|
2017
Q2 | $128M | Sell |
1,814,380
-924,240
| -34% | -$61.5M | 0.39% | 52 |
|
|
2017
Q1 | $186M | Buy |
2,738,620
+1,389,880
| +103% | +$97.7M | 0.49% | 39 |
|
|
2016
Q4 | $96.6M | Sell |
1,348,740
-1,431,010
| -51% | -$106M | 0.45% | 40 |
|
|
2016
Q3 | $220M | Buy |
2,779,750
+609,110
| +28% | +$49.5M | 0.91% | 18 |
|
|
2016
Q2 | $181M | Buy |
2,170,640
+8,430
| +0.4% | +$748K | 0.82% | 18 |
|
|
2016
Q1 | $199M | Sell |
2,162,210
-4,264,376
| -66% | -$385M | 0.84% | 19 |
|
|
2015
Q4 | $650M | Buy |
6,426,586
+4,183,803
| +187% | +$435M | 1.58% | 10 |
|
|
2015
Q3 | $220M | Sell |
2,242,783
-315,008
| -12% | -$35M | 0.55% | 25 |
|
|
2015
Q2 | $299M | Sell |
2,557,791
-469,966
| -16% | -$51.4M | 0.84% | 17 |
|
|
2015
Q1 | $297M | Sell |
3,027,757
-627,141
| -17% | -$63.7M | 0.82% | 19 |
|
|
2014
Q4 | $345M | Buy |
3,654,898
+289,658
| +9% | +$30M | 1.22% | 8 |
|
|
2014
Q3 | $358M | Buy |
3,365,240
+2,305,625
| +218% | +$226M | 0.31% | 54 |
|
|
2014
Q2 | $87.9M | Sell |
1,059,615
-49,499,815
| -98% | -$3.85B | 0.08% | 119 |
|
|
2014
Q1 | $16B | Buy |
50,559,430
+46,367,070
| +1,106% | +$3.64B | 12.39% | 1 |
|
|
2013
Q4 | $16.6B | Sell |
4,192,360
-23,434,880
| -85% | -$1.63B | 12.12% | 1 |
|
|
2013
Q3 | $6.81B | Sell |
27,627,240
-400,910
| -1% | -$24M | 4.95% | 3 |
|
|
2013
Q2 | $5.99B | Buy |
+28,028,150
| New | +$1.46B | 4.23% | 2 |
|
Other funds holding GILD
VCM
VPM
BNP Paribas Financial Markets's GILD Position: Q1 2026 in Review
BNP Paribas Financial Markets reduced its Gilead Sciences (GILD) stake by 33% in Q1 2026, selling an estimated $135M and leaving 1,966,938 shares worth $274M. The position accounts for 0.13% of the portfolio, ranked #144.
BNP Paribas Financial Markets first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $16.6B in Q4 2013. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- BNP Paribas Financial Markets held 1,966,938 shares of Gilead Sciences worth $274M as of Q1 2026.
- BNP Paribas Financial Markets sold 965,546 Gilead Sciences shares in Q1 2026, an estimated $135M.
- Gilead Sciences made up 0.13% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #144 holding.
- BNP Paribas Financial Markets first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- BNP Paribas Financial Markets's Gilead Sciences position peaked at $16.6B in Q4 2013.
- 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.